期刊文献+

耐药基因TopoⅡ及Ki-67在食管鳞癌的表达

The Expression of Topo Ⅱ and Ki-67 in Esophageal Squamous Cell Carcinoma
下载PDF
导出
摘要 目的探讨TopoⅡ及Ki-67在食管鳞癌的表达及其与肿瘤分化程度、淋巴结转移的关系。方法应用免疫组化检测75例食管鳞癌组织中TopoⅡ和Ki-67的表达情况。结果TopoⅡ和ki-67的表达与食管鳞癌的组织分化程度和淋巴结转移均有密切关系(P<0.05),并且TopoⅡ和ki-67阳性表达具有较强的一致性。结论检测TopoⅡ和ki-67的表达可作为判断食管鳞癌预后的重要指标。 Objective To discuss the expression of Topo II and Ki - 67 in esophageal sqauamous cell carcinoma and their relationship with the histodifferentiation grades and lymph node metastasis. Methods Immunohistochemistry was applied to study the expression. Results Topo Ⅱ and Ki - 67 were closely related to the histodifferentiation grades and lymph node metastasis of esophageal squamous cell carcinoma , and there existed a great consistence between the positive expression of Topo Ⅱ and Ki - 67. Conclusions The expression of Topo Ⅱ and Ki - 67 can be used as the important index in judging the prognosis of esophageal squamous cell carcinoma.
出处 《西南军医》 2008年第5期8-9,共2页 Journal of Military Surgeon in Southwest China
关键词 食管鳞癌 Top0Ⅱ KI-67 免疫组化 esophageal squamous cell carcinoma Topo Ⅱ Ki - 67 immunohistochemistry
  • 相关文献

参考文献4

二级参考文献19

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2[1]Eck SL, Alavi JB, Alavi A, et al. Treatment of advanced CNS malignancies with the recombinant adenovious H5. 010 RSVTK: a phase I trial. Hum Gene Ther, 1996,7(12): 1465~82.
  • 3[2]Furnari FB, Huang HJ. Genetics and malignant progression of human brain tumors. Cancer Surv, 1995,25:233~75.
  • 4[3]Dirks PB, Rutha JT. Current concepts in neuro-oncology, the cell cyclin -- review. Neurosurgery, 1997,40(5):1000~13.
  • 5[4]Nishikawa R, Furnari FB. Loss of P16ink4 expression if frequent in high grade gliomas. Cancer Res, 1995,5(9): 1941~5.
  • 6[6]Kumar S, Krenacs L, Ocsuki T, et al. Bcl-1 rearrangement and cyclinD1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol, 1996,105(6) :737~43.
  • 7[7]Drexler HG. Review of alternations of the cyclin-dependent kinase inhibitor INK-4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia, 1998,12(6): 845~ 59.
  • 8[8]Hirai H, Roussel MF, Kato JY, et al. Noval INK4 proteins p1 9 and p18 are specific inhibitors of the cyclin-D-dependent kinase CDK4and CDK6. Mol Cell Biol, 1995,15(5) :2672~81.
  • 9[9]Nishikawa R,Fumari FB. Loss of p16INK4 expression is frequent in high grade gliomas. Cancer Res, 1995,5(9): 1941 ~5.
  • 10[10]Serrano M, Hannon GJ, Beach DA. A new regulatory motify in cell-cycle control causing specific inhibition of cyclinD1/CDK4.Nature, 1993,366 ( 6465 ): 704~ 7.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部